Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
—
—
—
Lasa Supergenerics Limited is engaged in the manufacturing of anthelmintics/veterinary active pharmaceutical ingredient (API). The Company also manufactures bulk drugs
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Lasa Supergenerics Limited has informed the Exchange regarding Appointment of Mrs Varsha Joshi as Chief Financial Officer of the company w.e.f. July 25, 2024. | Download
Lasa Supergenerics Limited has informed the Exchange regarding Appointment of Mrs Varsha Joshi as Chief Financial Officer of the company w.e.f. July 25, 2024. | Download
Final • Div/Share: ₹ 0.25
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant